JDJan Domińczak

Jan Domińczak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jan Domińczak has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hormonal Cyclicity and Physical Performance - Review of the Literature

    by Gabriela Łuczyńska, Joanna Banatkiewicz, Sofia Czarnecka, Antoni Wojnowski, Jan Domińczak, Adam Dobosz, Emilia Deka, Hanna Bojanowska, Karolina Babik, Oliwia Bartkowska

    Introduction: The menstrual cycle involves a complex interaction of hormonal fluctuations that can influence various aspects of female athletic performance. Understanding these relationships has become increasingly important for optimizing training programs and supporting female athletes across different competitive levels. Objective: This review synthesizes current evidence on how menstrual cycle phases and hormonal contraception affect physical performance in female athletes. Material and methods: We conducted a comprehensive literature search across major databases including PubMed, Web of Science, and SPORTDiscus, focusing on studies published between 2020 and 2025 that examined menstrual cycle effects on athletic performance. Conclusions: Current evidence suggests that menstrual cycle phase effects on performance are generally small and highly individualized. While some athletes do experience performance decrements during specific phases particularly the early follicular and late luteal phases, group-level effects are often minimal or inconsistent. Interestingly, perceptual symptoms and psychological well-being appear to influence performance more consistently than hormonal fluctuations alone. Hormonal contraception shows variable effects depending on type and formulation. Rather than applying universal cycle-based training modifications, we recommend individual monitoring and personalized approaches.

  • Open Access

    Chronic Inflammation and Insulin Resistance as Links between Metabolic Syndrome and Musculoskeletal Disorders

    by Emilia Deka, Joanna Banatkiewicz, Oliwia Bartkowska, Sofia Czarnecka, Hanna Bojanowska, Karolina Babik, Gabriela Ewa Łuczyńska, Jan Domińczak, Adam Dobosz, Antoni Wojnowski

    Background: Metabolic syndrome (MetS) affects approximately 25-30% of adults worldwide and is traditionally associated with cardiovascular complications. However, emerging evidence suggests that MetS may also substantially increase the risk of musculoskeletal disorders, including osteoarthritis, sarcopenia, and osteoporosis. Objectives: This review synthesizes current evidence on the molecular and pathophysiological mechanisms connecting MetS to musculoskeletal disorders, with particular focus on chronic inflammation and insulin resistance as central mediators. Methods: A comprehensive literature search was conducted across PubMed and Google Scholar, focusing on publications from 2018-2026. Search terms included metabolic syndrome, chronic inflammation, insulin resistance, musculoskeletal disorders, adipokines, osteoarthritis, and sarcopenia. After reviewing and ranking for relevance, 40 high-impact studies were selected to form the evidence base for this review [40]. Results: The literature reveals that chronic inflammation in MetS, characterized by elevated pro-inflammatory cytokines (IL-6, TNF-α, IL-1β) and dysregulated adipokines (leptin, adiponectin, resistin), creates a systemic inflammatory environment that directly impacts musculoskeletal tissues. Conclusions: Chronic inflammation and insulin resistance represent critical mechanistic links between MetS and musculoskeletal disorders. Interventions targeting inflammation and insulin sensitivity—including lifestyle modifications, omega-3 fatty acids, metabolic drugs (metformin, GLP-1 agonists), intermittent fasting, and inflammasome-targeting approaches—may offer benefits for both metabolic and musculoskeletal health.

  • Open Access

    Muscle Imbalances and Their Role in Musculoskeletal Injury Risk in Physically Active Individuals: A narrative review

    by Adam Dobosz, Antoni Wojnowski, Jan Domińczak, Oliwia Bartkowska, Joanna Banatkiewicz, Emilia Deka, Sofia Czarnecka, Gabriela Łuczyńska, Karolina Babik, Hanna Bojanowska

    Introduction and Purpose: Muscle imbalances, particularly bilateral strength asymmetries and functional strength ratio deficits, are increasingly recognized as modifiable intrinsic risk factors for musculoskeletal injuries in physically active populations. This narrative review aims to synthesize current evidence on the definitions, mechanisms, assessment methods, and clinical implications of muscle imbalances regarding injury risk among athletes. Brief description of state of knowledge: Prospective studies indicate that bilateral strength asymmetries exceeding 10–15% are consistently associated with elevated injury risk, although specific thresholds depend on the muscle group and assessment method. Isokinetic dynamometry and force plate assessments are commonly employed for quantification. Evidence links quadriceps asymmetry, hamstring weakness, and adductor deficits to knee, hamstring, and groin injuries, respectively. Sport-specific demands significantly influence asymmetry profiles. Prevention strategies, such as targeted resistance training and neuromuscular interventions, are effective in reducing asymmetries. Summary (Conclusions): Muscle imbalances are critical risk factors requiring targeted intervention when exceeding sport-specific thresholds. Screening programs should utilize validated tools appropriate to the context. Future research must focus on methodological standardization and longitudinal studies. Clinicians are advised to implement individualized screening and corrective strategies within injury prevention frameworks.

  • Open Access

    Orthorexia Nervosa and Muscle Dysmorphia as Emerging Mental Health Threats in Athletes: A Comprehensive Narrative Review

    by Hanna Bojanowska, Gabriela Łuczyńska, Joanna Banatkiewicz, Emilia Deka, Jan Domińczak, Adam Dobosz, Oliwia Bartkowska, Karolina Babik, Sofia Czarnecka, Antoni Wojnowski

    Background: In modern sports, the line between healthy dedication and unhealthy obsession is becoming increasingly blurred. While classic eating disorders like anorexia and bulimia are well-known, Orthorexia Nervosa (ON) and Muscle Dysmorphia (MD) are growing problems that affect athletes of all genders but often go unnoticed. Objective: This review summarizes current knowledge regarding the prevalence, causes, and health consequences of ON and MD in athletes, based on literature acquired from PubMed, Embase, and Web of Science. Results: Evidence clearly shows that athletes are at a much higher risk for both conditions compared to the general population. Because strict diets and constant body monitoring are considered "normal" in sports, these disorders are often difficult to spot. Key risk factors include perfectionistic personality traits, pressure to meet weight requirements in certain sports, and the influence of social media, which promotes unrealistic body standards. Conclusion: Both ON and MD can lead to serious physical health issues, such as Relative Energy Deficiency in Sport (RED-S). Current findings highlight an urgent need for better screening tools designed specifically for athletes. Furthermore, a significant change in how we educate athletes and coaches about mental health and nutrition is necessary.

  • Open Access

    Guanfacine Extended Release in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Narrative Review

    by Sofia Czarnecka, Gabriela Łuczyńska, Joanna Banatkiewicz, Emilia Deka, Jan Domińczak, Adam Dobosz, Oliwia Bartkowska, Karolina Babik, Hanna Bojanowska, Antoni Wojnowski

    Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adolescents and is associated with substantial functional impairment. Although psychostimulants are considered first-line pharmacotherapy, a significant proportion of patients experience inadequate response, poor tolerability, or contraindications to stimulant use. Consequently, non-stimulant medications remain an important component of ADHD management. Guanfacine extended release (GXR), a selective α2A-adrenergic receptor agonist, is approved for the treatment of pediatric ADHD and represents a well-established non-stimulant option. Evidence derived from randomized controlled trials, meta-analyses, and systematic reviews indicates that GXR is effective as monotherapy and as adjunctive therapy to psychostimulants in children and adolescents aged 6–17 years. Across studies, GXR demonstrates clinically meaningful reductions in core ADHD symptoms compared with placebo, with reported effect sizes generally ranging from 0.5 to 0.8. The most commonly reported adverse events are sedation-related symptoms, including somnolence and fatigue, which are typically mild to moderate and tend to decrease with ongoing treatment. Cardiovascular effects are usually modest and consist mainly of small reductions in blood pressure and heart rate, with clinically significant events occurring infrequently. Overall, available data indicate that guanfacine extended release is an effective and generally well-tolerated non-stimulant treatment for ADHD in pediatric and adolescent populations. Its clinical utility is particularly relevant in patients with insufficient response or intolerance to stimulants, as well as in those requiring adjunctive pharmacotherapy. Further studies are warranted to evaluate long-term outcomes and to better define its comparative effectiveness in specific clinical subgroups.


  • Open Access

    Metabolic Adaptation and Weight Regain Phenomenon After Cessation of GLP-1 Analogue Pharmacotherapy

    by Karolina Babik, Oliwia Bartkowska, Joanna Banatkiewicz, Emilia Deka, Jan Domińczak, Sofia Czarnecka, Gabriela Łuczyńska, Adam Dobosz, Antoni Wojnowski, Hanna Maria Bojanowska

    Obesity is currently recognized as a chronic, relapsing and progressive disease, constituting one of the most serious public health challenges of the 21st century. The introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide and tirzepatide, has led to unprecedented therapeutic success, enabling weight reduction comparable to that achieved by bariatric surgery. However, despite their high efficacy, discontinuation of these agents is associated with rapid and clinically significant weight regain. The aim of this paper is to analyze the physiological mechanisms responsible for post-treatment weight regain following GLP-1 analogue withdrawal and to evaluate the effectiveness of selected strategies aimed at limiting this phenomenon, with particular emphasis on resistance training, nutritional interventions and pharmacological deprescribing models. Available clinical and experimental data indicate that weight regain is driven primarily by metabolic adaptation, including a disproportionate reduction in resting metabolic rate, loss of lean body mass and dysregulation of appetite-controlling hormones. Evidence from major clinical trials (STEP, SURMOUNT) confirms that up to two-thirds of the lost body weight may be regained within one year after cessation of therapy. The findings highlight the necessity of treating obesity pharmacotherapy as part of a long-term management strategy. Integration of pharmacological treatment with resistance training, high-protein dietary patterns and gradual dose reduction protocols appears essential for sustaining therapeutic effects and preventing the rebound phenomenon.

  • Open Access

    Regenerative Therapies for Articular Cartilage: Current Concepts, Clinical Outcomes, and Future Directions

    by Jan Domińczak, Adam Dobosz, Antoni Wojnowski, Sofia Czarnecka, Gabriela Łuczyńska, Joanna Banatkiewicz, Emilia Deka, Hanna Bojanowska, Karolina Babik, Oliwia Bartkowska

    Introduction and purpose. Articular cartilage injuries represent a significant clinical challenge due to the tissue’s limited intrinsic healing capacity, often progressing to osteoarthritis and chronic disability. Traditional treatments remain largely symptomatic, prompting extensive research into regenerative therapies aimed at restoring functional cartilage tissue. Description of the state of knowledge. We conducted a systematic analysis of recent literature (2020-2026) encompassing randomized controlled trials, systematic reviews, meta-analyses, and prospective cohort studies. Evidence was synthesized across multiple therapeutic modalities including mesenchymal stem cells (MSCs), autologous chondrocyte implantation (ACI/MACI), platelet-rich plasma (PRP), osteochondral transplantation, tissue engineering scaffolds, and emerging technologies such as 3D bioprinting, gene therapy, and exosome-based treatments. Matrix-associated autologous chondrocyte implantation (MACI) demonstrates significant long-term efficacy with large effect sizes (>0.8) in patient-reported outcomes at 2-15 years follow-up. Mesenchymal stem cells from various sources (bone marrow, adipose tissue, synovium, umbilical cord) show promise in clinical trials, with synovium-derived MSCs exhibiting particularly high chondrogenic potential. Comparative studies indicate that ACI/MACI and expanded MSC transplantation outperform microfracture for focal cartilage defects. Summary. Regenerative therapies have evolved significantly, with cell-based approaches demonstrating superior outcomes compared to traditional marrow stimulation techniques. However, challenges persist regarding optimal cell source, dosage, delivery methods, and long-term durability. Standardized protocols, large-scale randomized trials, and integration of emerging technologies are essential to advance the field toward personalized, effective cartilage regeneration strategies.


  • Open Access

    Management of Complex Fractures: Modern Approaches, Patient Outcomes, and Evolving Strategies

    by Antoni Wojnowski, Jan Domińczak, Adam Dobosz, Sofia Czarnecka, Gabriela Łuczyńska, Joanna Banatkiewicz, Emilia Deka, Hanna Bojanowska, Karolina Babik, Oliwia Bartkowska

    Introduction and Purpose: Complex fractures represent a significant challenge in orthopedic trauma, requiring sophisticated surgical techniques, multidisciplinary collaboration, and innovative fixation methods to optimize patient outcomes. This comprehensive review synthesizes current evidence on the management of complex fractures, focusing on modern surgical approaches, fixation innovations, patient outcomes, complications, and evolving treatment strategies. Description of the State of Knowledge: A narrative review was conducted across multiple databases, yielding 69 high-quality papers published primarily between 2020-2025, with selected seminal earlier studies included. Evidence was synthesized from systematic reviews, meta-analyses, randomized controlled trials, and prospective cohort studies addressing complex fracture management. Modern management emphasizes orthoplastic collaboration, minimally invasive techniques, and technological innovations including 3D printing, robotic-assisted surgery, and advanced imaging. Orthoplastic approaches demonstrate reduced infection rates (2.4-37%), with reported union rates ranging from >80% to near-complete union in selected series, and enhanced functional outcomes. Three-dimensional printing technology significantly reduces operative time, blood loss, and fluoroscopy use while improving anatomical reduction. Minimally invasive plate osteosynthesis achieves excellent functional outcomes in 65% of cases with rapid union rates. Complications remain a concern, with infection rates varying from 2.4% to 20% depending on fracture severity and management approach. Summary (Conclusions): Contemporary complex fracture management requires integrated multidisciplinary care, selective application of innovative technologies, and individualized treatment strategies. Future directions include artificial intelligence integration, personalized implant design, and enhanced biological augmentation strategies.

  • Open Access

    The use of platelet-rich plasma injections in the treatment of knee osteoarthritis - review of the literature

    by Joanna Banatkiewicz, Oliwia Bartkowska, Sofia Czarnecka, Gabriela Łuczyńska, Emilia Deka, Adam Dobosz, Jan Domińczak, Karolina Babik, Hanna Bojanowska, Antoni Wojnowski

    Introduction: Knee osteoarthritis (KOA) is one of the most common degenerative joint diseases, affecting millions of people worldwide. It is characterized by progressive cartilage degradation, chronic pain, joint stiffness, and functional impairment. Traditional treatment methods, including pharmacotherapy and intra-articular injections of corticosteroids or hyaluronic acid, provide limited and often short-term relief. Platelet-rich plasma (PRP) has emerged as a promising regenerative therapy due to its high concentration of growth factors that may stimulate tissue healing and reduce inflammation. Objective: The aim of this study is to review the latest literature on the use of platelet-rich plasma injections in patients with knee osteoarthritis. Material and methods: A literature review was conducted on databases such as PubMed, Google Scholar, and SciSpace using the terms: "knee osteoarthritis", "platelet-rich plasma", "PRP injections", "intra-articular injections", "knee OA treatment". Conclusions: Knee osteoarthritis is a highly prevalent condition that significantly impacts quality of life. Platelet-rich plasma has demonstrated positive effects on pain reduction and functional improvement in patients with KOA. PRP injections lead to superior outcomes compared to placebo and hyaluronic acid, with therapeutic effects lasting 12-24 months. However, there is lack of standardization in PRP preparation protocols, and further studies are necessary to establish optimal treatment parameters.

  • Open Access

    Sleep as an ‘Ergogenic Supplement’: The Role of Sleep Quality, Duration and Patterns in Preventing Sports Injuries - A Systematic Review

    by Oliwia Bartkowska, Joanna Banatkiewicz, Emilia Deka, Jan Domińczak, Sofia Czarnecka, Gabriela Ewa Łuczyńska, Adam Dobosz, Antoni Wojnowski, Karolina Babik, Hanna Maria Bojanowska

    BACKGROUND: Sleep is recognized as a key factor influencing athletic performance and injury prevention. Despite growing interest in sleep as a modifiable risk factor, the relationship between sleep parameters and the risk of sports injuries requires systematic evaluation. AIM: This study focuses on presenting the relationship between the duration, quality and patterns of sleep and the occurrence and prevention of sports injuries based on current knowledge. MATERIAL AND METHODS: This systematic review was conducted using multiple databases, including ScienceDirect, PubMed and Google Scholar. After removing duplicates, 165 unique articles compatible with the study topic were identified. The 31 most relevant articles were selected and used to analyse the association between sleep parameters and the effects of sports injuries in athlete populations. RESULTS: Strong evidence has been identified linking insufficient sleep to an increased risk of sports injuries in many groups of athletes. In addition, the study confirmed that poor sleep quality was associated with a significantly higher likelihood of injury. The study confirmed mechanisms connecting sleep and injury include impaired cognitive function, slowed reaction time, weakened neuromuscular control, increased inflammation and impaired tissue regeneration. CONCLUSIONS: Evidence shows that sleep has a protective effect against injuries when it is sufficiently long and of adequate quality. Healthcare professionals, coaches and athletes should prioritise sleep hygiene measures as part of comprehensive injury prevention strategies.